
Webinar Date/Time: Wed, Jan 22, 2025 11:00 AM EST
Webinar Date/Time: Wed, Jan 22, 2025 11:00 AM EST
Are you tired of clinical trial technology that slows down processes? Are your sites looking for more intuitive solutions? At YPrime, we’ve taken a deep dive into site experiences and perspectives, sharing ways to bridge the gap between sponsors, sites, and patients, to foster a more efficient clinical trial process.
Webinar Date/Time: Wed, Oct 23, 2024 11:00 AM EDT
Webinar Date/Time: Wed, Sep 25, 2024 11:00 AM EDT
Do you leverage a quality-first mindset as you evaluate clinical trial technology? When you evaluate eCOA and IRT solutions, quality cannot be ignored, as choosing poorly can lead to data integrity issues, regulatory roadblocks, and costly delays that can postpone potentially lifesaving treatments. How can you ensure your clinical trial technology partner prioritizes quality throughout the clinical research journey? This checklist is your guide to choosing a quality-first solution.
Webinar Date/Time: Wed, Jul 17, 2024 1:00 PM EDT
Is your eCOA provider built to deliver clinical trial success? Our eCOA checklist provides key questions to ask when evaluating potential vendors.
YPrime announces a new report unveiling the top challenges that clinical trial executives face when implementing eCOA, and what to look for when evaluating new solutions.
Webinar Date/Time: Thu, Mar 28, 2024 12:00 PM EDT
Webinar Date/Time: Wednesday, December 7th, 2022 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Tuesday, May 3, 2022 at 11am EDT | 7am PDT | 3pm BST | 4pm CEST What can the eClinical technology industry learn from consumer-focused technology companies? They can learn effective approaches that help engage, incentivize, and motivate patients in clinical trials, to improve recruitment and decrease attrition.
YPrime President, Mark Maietta, discusses the future of decentralized clinical trials following Covid-19. Adaptations will need to be made as DCT is here to stay.
A direct-to-patient (DtP) clinical trial design, where investigational medicinal products (IMP) and clinical supplies are shipped or delivered directly to patients, fits within a decentralized clinical trial (DCT) model. Although patients, sites, and sponsors can all benefit from this trial design, there are unique complexities to DtP trials, that can be managed with advanced technology. Learn about this trial strategy, the unique challenges, what the industry is doing to address these challenges and how technology can help facilitate adoption of this trial design.
Published: February 13th 2025 | Updated: March 4th 2025
Published: February 19th 2025 | Updated: February 26th 2025
Published: March 24th 2023 | Updated:
Published: April 28th 2021 | Updated:
Published: July 26th 2024 | Updated:
Published: January 31st 2024 | Updated: